Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Family history of convulsions and use of pertussis vaccine.

Livengood JR, Mullen JR, White JW, Brink EW, Orenstein WA.

J Pediatr. 1989 Oct;115(4):527-31.

PMID:
2552066
2.

History of convulsions and use of pertussis vaccine.

Stetler HC, Orenstein WA, Bart KJ, Brink EW, Brennan JP, Hinman AR.

J Pediatr. 1985 Aug;107(2):175-9.

PMID:
3874940
3.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
4.

Adverse events following immunization with DTP vaccine.

Stetler HC, Mullen JR, Brennan JP, Orenstein WA, Bart KJ, Hinman AR.

Dev Biol Stand. 1985;61:411-21.

PMID:
3879686
6.
7.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

10.
11.

Active surveillance of vaccine safety: a system to detect early signs of adverse events.

Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, Platt R, Black S, Shinefield H, Chen RT.

Epidemiology. 2005 May;16(3):336-41.

PMID:
15824549
12.

Contraindications to pertussis vaccine.

Pan American Health Organization PAHO. Expanded Program on Immunization EPI. Immunization Practices Advisory Committee.

EPI Newsl. 1984 Aug;6(4):1-2.

PMID:
12281268
13.

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE.

Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7. Dutch.

PMID:
18225797
14.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
16.
17.

Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine.

Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W.

JAMA. 1990 Mar 23-30;263(12):1641-5.

PMID:
2308203
19.

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.

Rosenthal S, Chen R, Hadler S.

Arch Pediatr Adolesc Med. 1996 May;150(5):457-60.

PMID:
8620224
20.

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk